Strengthens Patent Portfolio Protecting Horsepox-Based Live Virus Vaccines TNX-1840 and TNX-1850 are Potential RPV Vaccines Designed to Protect Against COVID-19 Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something … Continue reading Tonix Pharmaceuticals (NASDAQ: TNXP) Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology